Docusign (NASDAQ:DOCU – Get Free Report) had its price target upped by equities researchers at UBS Group from $54.00 to $70.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective indicates a potential upside of 6.68% from the stock’s previous close.
Other research analysts also recently issued research reports about the company. Wedbush cut their price target on Docusign from $60.00 to $58.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. Jefferies Financial Group lifted their price objective on Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a research note on Friday, June 5th. Wells Fargo & Company set a $60.00 price objective on Docusign in a report on Friday. Citigroup reissued a “neutral” rating on shares of Docusign in a research note on Friday. Finally, Evercore set a $65.00 target price on Docusign in a report on Friday. Three equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $64.33.
View Our Latest Analysis on DOCU
Docusign Price Performance
Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The firm had revenue of $875.75 million for the quarter, compared to analysts’ expectations of $867.22 million. During the same period last year, the firm earned $0.30 earnings per share. The business’s revenue for the quarter was up 9.4% on a year-over-year basis. As a group, analysts expect that Docusign will post 2.03 EPS for the current year.
Insider Activity at Docusign
In other Docusign news, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $45.54, for a total value of $546,480.00. Following the sale, the insider owned 52,815 shares of the company’s stock, valued at $2,405,195.10. This trade represents a 18.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Paula Hansen sold 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $273,240.00. Following the completion of the sale, the executive owned 89,972 shares in the company, valued at $4,097,324.88. The trade was a 6.25% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 90,602 shares of company stock valued at $4,323,749 over the last 90 days. Insiders own 0.59% of the company’s stock.
Institutional Trading of Docusign
A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. acquired a new position in Docusign during the second quarter worth $927,059,000. California State Teachers Retirement System increased its stake in Docusign by 4,016.6% in the 2nd quarter. California State Teachers Retirement System now owns 9,960,652 shares of the company’s stock valued at $442,452,000 after buying an additional 9,718,686 shares during the last quarter. State Street Corp increased its stake in Docusign by 0.9% in the 4th quarter. State Street Corp now owns 8,193,805 shares of the company’s stock valued at $560,456,000 after buying an additional 77,008 shares during the last quarter. Capital World Investors lifted its position in Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after buying an additional 1,603,900 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of Docusign by 76.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock worth $250,568,000 after buying an additional 2,283,996 shares during the last quarter. Institutional investors own 77.64% of the company’s stock.
Key Docusign News
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Quarterly results beat expectations: Fiscal Q2 revenue rose 9.4% year over year to $875.7 million, exceeding the $867.2 million consensus estimate. Adjusted EPS of $1.16 also topped expectations of approximately $1.08–$1.09, compared with $0.92 a year earlier. Docusign Announces Second Quarter Fiscal 2027 Financial Results
- Positive Sentiment: Raised full-year outlook: Docusign increased fiscal 2027 guidance for revenue, annual recurring revenue (ARR), and IAM’s share of total ARR. Full-year revenue guidance of approximately $3.5 billion was broadly in line with consensus, while third-quarter revenue guidance of $886 million–$890 million was near analysts’ $888.2 million estimate. Docusign Raises Full-Year Forecast on AI Momentum
- Positive Sentiment: AI growth narrative is gaining traction: Management cited accelerating IAM adoption and AI-related demand as drivers of the improved outlook. Docusign also plans to make its Model Context Protocol server available to every AI agent on September 30, positioning its agreement technology as an infrastructure layer for enterprise AI workflows. Docusign Agreement Layer for the Agentic Enterprise Coming to Every Agent
- Positive Sentiment: Analyst price-target support: BTIG raised its Docusign price target to $75, while Morgan Stanley also boosted its target, adding to the bullish reaction following the earnings report. BTIG Boosts Docusign Price Target
- Neutral Sentiment: Mixed technical and analyst signals: DOCU has formed a bullish “golden cross” and trades well above its 200-day moving average, but Needham reaffirmed a “hold” rating, indicating that some analysts believe the recent rally may already reflect much of the improved outlook.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- Defense Stocks Are Pulling Back as Their Navy Tailwinds Get Stronger
- Survey Reveals: America’s Top Autumn Activities that are Free [2026]
- Defying Gravity: Space Stocks Reach Escape Velocity
- Credo Technology Just Plunged 20%—Did the Market Overreact?
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
